How Interim Analyses Work

Christos P. Kotanidis(University of Oxford), Chana A. Sacks(Harvard University), Sharon‐Lise T. Normand(Harvard University), Daniel J. Müller(Board of the Swiss Federal Institutes of Technology), Adam Straus, Alison E. Burke, Sarah Gorey(Royal College of Physicians of Ireland), Kim Knoper, C. Corey Hardin(Massachusetts General Hospital)

NEJM Evidence

March 25, 2025

10.1056/evidstat2500047

Cited by 0

Related Papers

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

|New England Journal of Medicine|2020|1.4k

<scp>GSDMD</scp> membrane pore formation constitutes the mechanism of pyroptotic cell death

|The EMBO Journal|2016|1.2k

Tau protein liquid–liquid phase separation can initiate tau aggregation

|The EMBO Journal|2018|1.1k

Criteria for Evaluation of Novel Markers of Cardiovascular Risk

|Circulation|2009|1.1k

Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data

|The Lancet|2018|1.1k